Skip to main content

Main menu

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Other Publications
    • cbm

User menu

  • My alerts

Search

  • Advanced search
Cancer Biology & Medicine
  • Other Publications
    • cbm
  • My alerts
Cancer Biology & Medicine

Advanced Search

 

  • Home
  • About
    • About CBM
    • Editorial Board
    • Announcement
  • Articles
    • Ahead of print
    • Current Issue
    • Archive
    • Collections
    • Cover Story
  • For Authors
    • Instructions for Authors
    • Resources
    • Submit a Manuscript
  • For Reviewers
    • Become a Reviewer
    • Instructions for Reviewers
    • Resources
    • Outstanding Reviewer
  • Subscription
  • Alerts
    • Email Alerts
    • RSS Feeds
    • Table of Contents
  • Contact us
  • Follow cbm on Twitter
  • Visit cbm on Facebook

Index by author

May 15, 2022; Volume 19,Issue 5
  • A
  • B
  • C
  • D
  • E
  • F
  • G
  • H
  • I
  • J
  • K
  • L
  • M
  • N
  • O
  • P
  • Q
  • R
  • S
  • T
  • U
  • V
  • W
  • X
  • Y
  • Z

  1. Artemyeva, Anna

    1. You have access
      Immunology and immunotherapy in breast cancer
      Vladimir Semiglazov, Andrey Tseluiko, Asel Kudaybergenova, Anna Artemyeva, Petr Krivorotko and Roman Donskih
      Cancer Biology & Medicine May 2022, 19 (5) 609-618; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0597
  2. Cao, Huiya

    1. You have access
      Comprehensive characterization of CRC with germline mutations reveals a distinct somatic mutational landscape and elevated cancer risk in the Chinese population
      Jianfei Yao, Yunhuan Zhen, Jing Fan, Yuan Gong, Yumeng Ye, Shaohua Guo, Hongyi Liu, Xiaoyun Li, Guosheng Li, Pan Yang, Xiaohui Wang, Danni Liu, Tanxiao Huang, Huiya Cao, Peisu Suo, Yuemin Li, Jingbo Yu and Lele Song
      Cancer Biology & Medicine May 2022, 19 (5) 707-732; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0190
  3. Chen, Kexin

    1. You have access
      Improved diagnosis of thyroid cancer aided with deep learning applied to sonographic text reports: a retrospective, multi-cohort, diagnostic study
      Qiang Zhang, Sheng Zhang, Jianxin Li, Yi Pan, Jing Zhao, Yixing Feng, Yanhui Zhao, Xiaoqing Wang, Zhiming Zheng, Xiangming Yang, Lixia Liu, Chunxin Qin, Ke Zhao, Xiaonan Liu, Caixia Li, Liuyang Zhang, Chunrui Yang, Na Zhuo, Hong Zhang, Jie Liu, Jinglei Gao, Xiaoling Di, Fanbo Meng, Wei Ji, Meng Yang, Xiaojie Xin, Xi Wei, Rui Jin, Lun Zhang, Xudong Wang, Fengju Song, Xiangqian Zheng, Ming Gao, Kexin Chen and Xiangchun Li
      Cancer Biology & Medicine May 2022, 19 (5) 733-741; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0509
  4. Chen, Li

    1. You have access
      Platinum is essential in neoadjuvant treatment of triple-negative breast cancer: a network meta-analysis
      Junjie Li, Li Chen, Wei Tan, Fang Qi, Yang Zhang, Zhonghua Wang and Zhimin Shao
      Cancer Biology & Medicine May 2022, 19 (5) 742-754; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0529
  5. Chen, Miaomiao

    1. You have access
      Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion via integrin/BRAF/TAK1/ERK/ETV4 signaling
      Panpan Ma, Xinxin Jin, Zhiwei Fan, Zhou Wang, Suhui Yue, Changyue Wu, Shiyin Chen, Yuanyuan Wu, Miaomiao Chen, Donghua Gu, Siliang Zhang, Renfang Mao and Yihui Fan
      Cancer Biology & Medicine May 2022, 19 (5) 669-684; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0137
  6. Chen, Shiyin

    1. You have access
      Super-enhancer receives signals from the extracellular matrix to induce PD-L1-mediated immune evasion via integrin/BRAF/TAK1/ERK/ETV4 signaling
      Panpan Ma, Xinxin Jin, Zhiwei Fan, Zhou Wang, Suhui Yue, Changyue Wu, Shiyin Chen, Yuanyuan Wu, Miaomiao Chen, Donghua Gu, Siliang Zhang, Renfang Mao and Yihui Fan
      Cancer Biology & Medicine May 2022, 19 (5) 669-684; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0137
  7. Chen, Yali

    1. You have access
      Effects of population aging on the mortality burden of related cancers in urban and rural areas of China, 2004–2017: a population-based study
      Yali Chen, Cuihong Yang, Ning Li, Zixing Wang, Peng Wu, Jin Du and Jingmei Jiang
      Cancer Biology & Medicine May 2022, 19 (5) 696-706; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0538
  8. Cheng, Bo

    1. You have access
      Advances in lung cancer screening and early detection
      Caichen Li, Huiting Wang, Yu Jiang, Wenhai Fu, Xiwen Liu, Ran Zhong, Bo Cheng, Feng Zhu, Yang Xiang, Jianxing He and Wenhua Liang
      Cancer Biology & Medicine May 2022, 19 (5) 591-608; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0690
  9. Cheng, Ruochuan

    1. You have access
      The active surveillance management approach for patients with low risk papillary thyroid microcarcinomas: is China ready?
      Wen Liu, Xuejing Yan and Ruochuan Cheng
      Cancer Biology & Medicine May 2022, 19 (5) 619-634; DOI: https://doi.org/10.20892/j.issn.2095-3941.2021.0058
  10. Cui, Mingke

    1. You have access
      The choice of a neoadjuvant chemotherapy cycle for breast cancer has significance in clinical practice: results from a population-based, real world study
      Litong Yao, Zhiyuan Pang, Mozhi Wang, Mengshen Wang, Xiangyu Sun, Mingke Cui, Yanfu Zheng, Xinyan Li, Haoran Dong, Qiang Zhang and Yingying Xu
      Cancer Biology & Medicine May 2022, 19 (5) 755-767; DOI: https://doi.org/10.20892/j.issn.2095-3941.2020.0800
« Previous (Pages : 1 2 3 4 5 6 ... 15) Next »
Back to top
PreviousNext

In this issue

Cancer Biology & Medicine: 19 (5)
Cancer Biology & Medicine
Vol. 19, Issue 5
15 May 2022
  • Table of Contents
  • Index by author

Submit

Sign up for alerts

  • Top Topics
  • Most Cited
  • Most Read
Loading
The advanced development of molecular targeted therapy for hepatocellular carcinoma
The efficacies and biomarker investigations of anti-programmed death-1 (anti-PD-1)-based therapies for metastatic bone and soft tissue sarcoma
Immunology and immunotherapy in breast cancer
Effects of menopausal hormone therapy-based on the role of estrogens, progestogens, and their metabolites in proliferation of breast cancer cells
Breast cancer screening and early diagnosis in Chinese women
Is adjuvant chemotherapy necessary for early gastric cancer?
Modulating microRNAs in cancer: next-generation therapies
Safety and efficacy of anti-EGFR monoclonal antibody (SCT200) as second-line therapy in advanced esophageal squamous cell carcinoma
Personalized immunotherapy in cancer precision medicine
Cellular immunotherapy for hematological malignancy: recent progress and future perspectives

Navigate

  • Home
  • Current Issue

More Information

  • About CBM
  • About CACA
  • About TMUCIH
  • Editorial Board
  • Subscription

For Authors

  • Instructions for authors
  • Journal Policies
  • Submit a Manuscript

Journal Services

  • Email Alerts
  • Facebook
  • RSS Feeds
  • Twitter

 

© 2025 Cancer Biology & Medicine

Powered by HighWire